Status | Study |
Not yet recruiting |
Study Name: Harnessing Placebo Effects in Methadone Treatment Condition: Opioid-related Disorders Date: 2016-10-19 Interventions: Behavioral: Placebo Dose-Extension pill |
Not yet recruiting |
Study Name: BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3 Condition: Opioid-related Disorders Date: 2016-08-12 Interventions: Behavioral: BUP_FAST Peer ment |
Completed |
Study Name: Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers Condition: Opioid-Related Disorders Date: 2016-04-21 Interventions: Drug: Naltrexone Other: Intravail |
Not yet recruiting |
Study Name: Computer-based Prescription Opioid Abuse Prevention for Adolescents Condition: Opioid Related Disorders Date: 2016-03-14 Interventions: Behavioral: Web-based prescription opioid prevention for adolescents |
Terminated |
Study Name: Comparative Evaluation of PUSPENs and C&Cs Condition: Opioid-Related Disorders Date: 2016-02-16 Interventions: Drug: Methadone |
Recruiting |
Study Name: Buprenorphine Group Medical Visits in Primary Care Condition: Opioid-Related Disorders Date: 2015-07-24 Interventions: Behavioral: G-BMT The G-BMT in |
Recruiting |
Study Name: Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access Condition: Opioid-related Disorders Date: 2015-02-05 Interventions: Drug: Interim Buprenorphine Treatment (IBT) The Interim Bu |
Completed |
Study Name: Trial of Methadone Maintenance Versus Methadone Detox in Jail Condition: Opioid-Related Disorders Date: 2013-06-05 Interventions: Behavioral: Methadone Maintenance |
Completed |
Study Name: Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users Condition: Opioid-Related Disorders Date: 2012-12-18 Interventions: Drug: Hydrocodone/Acetaminophen |
Completed |
Study Name: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects Condition: Opioid Related Disorder Date: 2012-11-28 Interventions: Drug: RBP-6000 18% Buprenorphi |